Sino Biopharmaceutical Ltd - Company Profile
Powered by
All the data and insights you need on Sino Biopharmaceutical Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Sino Biopharmaceutical Ltd Strategy Report
- Understand Sino Biopharmaceutical Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Sino Biopharmaceutical Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
21 Sep 2022 | Chia Tai Tianqing Pharma Enters into Licensing Agreement with Inventiva | Licensing Agreement |
Chia Tai Tianqing Pharmaceutical Group Co Ltd
|
Inventiva SA
|
02 Jun 2022 | Yifan Pharma and Sino Biopharma Invest USD70 Million in Yiyi Biopharma | Equity Offering |
Sino Biopharmaceutical Ltd
Yifan Pharmaceutical Co Ltd
|
Yiyi Biopharmaceutical (Beijing) Co., Ltd.
|
18 May 2022 | Chia Tai-Tianqing Pharma to Acquire Monoclonal Antibody from Symphogen | Asset Transaction |
Chia Tai Tianqing Pharmaceutical Group Co Ltd
|
Symphogen A/S
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer